Can-Fite BioPharma Ltd. Income Tax Expense Continuing Operations
Can-Fite BioPharma Ltd. (CANF) reported Income Tax Expense Continuing Operations of $4.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2020-03-27.
Discontinued › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2020-03-27
| Period end | Income Tax Expense Continuing Operations 12 month | Income Tax Expense Continuing Operations 12 month as first filed |
|---|---|---|
| 2018-12-31 | $4.00K 20-F · filed 2020-03-27 | |
| 2017-12-31 | $29.00K 20-F · filed 2020-03-27 | $30.00K 20-F · filed 2018-03-28 |
| 2016-12-31 | $29.00K 20-F · filed 2019-03-29 | |
| 2015-12-31 | $5.00K 6-K · filed 2018-08-08 |